| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Omar M E Abdel-Sala. Antinociceptive and behavioral effects of ribavirin in mice. Pharmacology, biochemistry, and behavior. vol 83. issue 2. 2006-08-14. PMID:16563475. |
further, the ribavirin induced antinociception was enhanced by d2 receptor antagonists haloperidol, sulpiride, clozapine or domperidone and by the dopamine d2 receptor agonist bromocryptine. |
2006-08-14 |
2023-08-12 |
mouse |
| Q David Walker, Rupa Ray, Cynthia M Kuh. Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 6. 2006-08-07. PMID:16237396. |
the typical antipsychotic, haloperidol, increased dopamine efflux in both sexes but the effect was twice as large in the female striatum. |
2006-08-07 |
2023-08-12 |
rat |
| Filomena Mattner, Karine Mardon, Christian Loc'h, Andrew Katsifi. Pharmacological evaluation of an [(123)I] labelled imidazopyridine-3-acetamide for the study of benzodiazepine receptors. Life sciences. vol 79. issue 3. 2006-08-04. PMID:16464478. |
flumazenil, a central benzodiazepine drug and haloperidol (dopamine antagonist/sigma receptor drug) displayed no effect in [(123)i]izol in peripheral organs and in the brain. |
2006-08-04 |
2023-08-12 |
rat |
| Glenn W Stevenson, Edward J Bilsky, S Stevens Negu. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. The journal of pain. vol 7. issue 6. 2006-07-27. PMID:16750797. |
morphine (1 mg/kg) prevented both acid-induced writhing and acid-induced suppression of feeding, whereas the dopamine antagonist haloperidol inhibited writhing without preventing acid-induced suppression of feeding. |
2006-07-27 |
2023-08-12 |
mouse |
| Ewa Obuchowicz, Zbigniew S Herma. Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system. Pharmacological reports : PR. vol 57. issue 6. 2006-07-21. PMID:16382207. |
none of the receptor ligands studied: the dopamine d2 antagonist eticlopride, d2/d3 antagonist haloperidol, alpha1-adrenergic antagonist prazosin, n-methyl-d-aspartate antagonist mk-801, 5-ht2/d2 antagonist mianserin, d2/d3 agonist quinpirole and alpha2-adrenergic agonist clonidine co-administrated with repeated amphetamine (amph) injections blocked the amph-induced decrease in the striatal and nucleus accumbens neuropeptide y (npy) levels. |
2006-07-21 |
2023-08-12 |
rat |
| L Fontana, A S Souza, E A Del Bel, R M W de Oliveir. Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 38. issue 11. 2006-07-10. PMID:16258634. |
l g-nitro-arginine (l-noarg), a nitric oxide synthase inhibitor, and haloperidol, a drug that blocks dopamine receptors, are both known to induce catalepsy in rodents. |
2006-07-10 |
2023-08-12 |
mouse |
| Cristina Cosi, Elisabeth Carilla-Durand, Marie Bernadette Assié, Anne Marie Ormiere, Mireille Maraval, Nathalie Leduc, Adrian Newman-Tancred. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. European journal of pharmacology. vol 535. issue 1-3. 2006-06-21. PMID:16554049. |
we compared the effects of the new antipsychotic agents ssr181507 ((3-exo)-8-benzoyl-n-[[(2 s)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl]methyl]-8-azabicyclo[3.2.1]octane-3-methanamine monohydrochloride), bifeprunox (du127090: 1-(2-oxo-benzoxazolin-7-yl)-4-(3-biphenyl)methylpiperazinemesylate) and slv313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4-[5-(4-fluorophenyl)-pyridin-3-ylmethyl]-piperazine) with those of aripiprazole (7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]-butyloxy)-3,4-dihydro-2(1 h)-quinolinone), clozapine and haloperidol, on functional measures of dopamine d2 receptor activity in vitro and in vivo: [35s]-gtpgammas binding to membranes from sf9 insect cells expressing human dopamine d2 long (hd2 l) receptors, and serum prolactin levels in the rat. |
2006-06-21 |
2023-08-12 |
human |
| Claire Roberts, Robert Cummins, Zaira Gnoffo, James N C Ke. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. European journal of pharmacology. vol 534. issue 1-3. 2006-06-07. PMID:16490190. |
clozapine, haloperidol, sulpiride and the selective dopamine d3 receptor antagonist, sb-277011-a, had no effect on dopamine efflux per se but all attenuated the (+/-)7-oh-dpat-induced-inhibition of dopamine efflux, with pa2 values of 6.6, 7.9, 7.0 and 7.6, respectively. |
2006-06-07 |
2023-08-12 |
rat |
| Claire Roberts, Robert Cummins, Zaira Gnoffo, James N C Ke. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. European journal of pharmacology. vol 534. issue 1-3. 2006-06-07. PMID:16490190. |
in contrast, haloperidol and sulpiride significantly increased dopamine efflux through a d2 receptor-mediated mechanism. |
2006-06-07 |
2023-08-12 |
rat |
| Juan Bustillo, Ranee Barrow, Rodrigo Paz, Jennifer Tang, Navid Seraji-Bozorgzad, Gregory J Moore, Federico Bolognani, John Lauriello, Nora Perrone-Bizzozero, Matthew P Gallowa. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 4. 2006-05-25. PMID:16132064. |
a prolonged exposure to the dopamine d2 receptor blockade effects of haloperidol does not result in changes in naa, glutamate, glutamine, and other metabolites in the proton spectrum. |
2006-05-25 |
2023-08-12 |
rat |
| Kotaro Hattori, Shigeo Uchino, Tomoko Isosaka, Mamiko Maekawa, Masaomi Iyo, Toshio Sato, Shinichi Kohsaka, Takeshi Yagi, Shigeki Yuas. Fyn is required for haloperidol-induced catalepsy in mice. The Journal of biological chemistry. vol 281. issue 11. 2006-05-10. PMID:16407246. |
expression of the striatal dopamine d(2) receptor, the main site of haloperidol action, did not differ between the two genotypes. |
2006-05-10 |
2023-08-12 |
mouse |
| Nadine Kabbani, Robert Levenso. Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. Neuroreport. vol 17. issue 3. 2006-05-09. PMID:16462601. |
here, we examined the effects of chronic haloperidol and clozapine on cortical d2 dopamine receptors and six different dopamine receptor interacting proteins. |
2006-05-09 |
2023-08-12 |
Not clear |
| Nadine Kabbani, Robert Levenso. Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. Neuroreport. vol 17. issue 3. 2006-05-09. PMID:16462601. |
using comparative immunoblot analysis, we found that treatment with either haloperidol or clozapine increased d2 dopamine receptors, calcium activator protein for secretion, protein 4.1n, and neuronal calcium sensor-1 expression. |
2006-05-09 |
2023-08-12 |
Not clear |
| Sanna Janhunen, Paula Mielikäinen, Päivi Paldánius, Raimo K Tuominen, Liisa Ahtee, Seppo Kaakkol. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats. Naunyn-Schmiedeberg's archives of pharmacology. vol 371. issue 6. 2006-04-28. PMID:16012872. |
we used brain microdialysis to study the effects of nicotine on extracellular levels of dopamine (da) and its metabolites in the rat dorsal striatum in combination with drugs inhibiting either da uptake (nomifensine), catechol-o-methyltransferase (comt; tolcapone), monoamine oxidase b (mao-b; selegiline) or da receptors (haloperidol). |
2006-04-28 |
2023-08-12 |
rat |
| Carsten Saft, Thorsten Lauter, Peter H Kraus, Horst Przuntek, Juergen E Andric. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series. BMC neurology. vol 6. 2006-04-28. PMID:16507108. |
chorea in huntington's disease (hd) is usually treated with antidopaminergic neuroleptics like haloperidol, olanzapine and tiaprid or dopamine depleting drugs like tetrabenazine. |
2006-04-28 |
2023-08-12 |
Not clear |
| Susanne Nikolaus, Rolf Larisch, Andreas Wirrwar, Marlyse Jamdjeu-Nouné, Christina Antke, Markus Beu, Nils Schramm, Hans-Wilhelm Mülle. [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT. European journal of nuclear medicine and molecular imaging. vol 32. issue 11. 2006-04-17. PMID:16003562. |
[123i]iodobenzamide binding to the rat dopamine d2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal spect. |
2006-04-17 |
2023-08-12 |
rat |
| Susanne Nikolaus, Rolf Larisch, Andreas Wirrwar, Marlyse Jamdjeu-Nouné, Christina Antke, Markus Beu, Nils Schramm, Hans-Wilhelm Mülle. [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT. European journal of nuclear medicine and molecular imaging. vol 32. issue 11. 2006-04-17. PMID:16003562. |
this study assessed [123i]iodobenzamide binding to the rat dopamine d2 receptor in competition with haloperidol and endogenous dopamine using a high-resolution small animal spect. |
2006-04-17 |
2023-08-12 |
rat |
| Yavuz S Silay, Joseph Jankovi. Emerging drugs in Tourette syndrome. Expert opinion on emerging drugs. vol 10. issue 2. 2006-04-14. PMID:15934872. |
although haloperidol and pimozide are the only drugs currently approved by the fda for the treatment of ts, other dopamine receptor-blocking drugs and tetrabenazine, a dopamine depleting drug, as well as botulinum toxin injections, have been used to treat tics associated with ts. |
2006-04-14 |
2023-08-12 |
Not clear |
| M Lazzarini, C Salum, E A Del Be. Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice. Psychopharmacology. vol 181. issue 1. 2006-04-10. PMID:15806417. |
drugs like haloperidol (hal) that decrease dopamine (da) neurotransmission in the striatum induce catalepsy in rodents and parkinson disease-like symptoms in humans. |
2006-04-10 |
2023-08-12 |
mouse |
| Briar Thompson, Kevin C Leonard, Stefan M Brudzynsk. Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis. Behavioural brain research. vol 168. issue 1. 2006-04-04. PMID:16343652. |
however, another d2 dopamine receptor antagonist, haloperidol, which is known to increase the accumbens dopamine level, was ineffective in reversing the increase in call number at the dose studied. |
2006-04-04 |
2023-08-12 |
rat |